Article
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
1 Sept 2021
Abstract excerpt
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to identify pathophysiological characteristics leading to severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human leukocyte antigen alleles (HLA) have been suggested as potential genetic host factors that affect individual immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
